Butler John P.

Avg. Two Year Performance

(9%) Avg. Purchase Return
(4%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return58%112%167%(1%)(9%)
Purchase Success Rate3 of 42 of 41 of 42 of 40 of 4
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 40 of 40 of 40 of 40 of 4

Akebia Therapeutics, Inc.

Drugs » Biotechnology

CEO and President, Director:

Holdings: 2.36M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Keryx Biopharmaceuticals Inc.

Drugs » Drug Manufacturers - Major

Director:

Holdings: 20.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Relypsa Inc

Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Zynerba Pharmaceuticals, Inc.

Drugs » Drugs - Generic

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--